Vergoeding 2017-2021 voor ATC-subgroep C08CA : Dihydropyridinederivaten
- Raming voor de totale Zvw-populatie
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| C08CA01 Amlodipine (Norvasc ®) | 3.620.700 | 3.575.600 | 5.096.800 | 5.527.100 | 5.681.200 |
| C08CA02 Felodipine (Plendil ®) | 588.800 | 569.890 | 576.850 | 556.550 | 525.560 |
| C08CA03 Isradipine | 204.200 | 48.923 | 488 | . | . |
| C08CA04 Nicardipine | 53 | . | . | . | . |
| C08CA05 Nifedipine (Nifedipin-ratiopharm ®) | 6.770.700 | 6.580.200 | 7.208.500 | 6.827.700 | 6.846.100 |
| C08CA06 Nimodipine (Nimotop ®) | 11.530 | 16.337 | 12.952 | 15.134 | 14.992 |
| C08CA08 Nitrendipine | 57.574 | 24.733 | . | . | . |
| C08CA09 Lacidipine | 85.885 | 84.288 | 75.901 | 75.808 | 80.848 |
| C08CA12 Barnidipine (Cyress ®) | 16.926.900 | 17.858.600 | 18.026.600 | 18.686.600 | 19.466.500 |
| C08CA13 Lercanidipine (Lerdip ®) | 904.890 | 959.440 | 1.102.800 | 1.228.300 | 1.299.500 |
| Totaal | 29.171.232 | 29.718.011 | 32.100.891 | 32.917.192 | 33.914.700 |